Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21217825 | 0.80 | RAB9A (0.36) | ALDH1A1 | |
| SCHEMBL8182082 | 0.74 | — | — | |
| SCHEMBL16016678 | 0.70 | — | — | |
| SCHEMBL10159729 | 0.67 | — | — | |
| SCHEMBL11317755 | 0.67 | — | — | |
| SCHEMBL231287 | 0.65 | — | — | |
| SCHEMBL1930807 | 0.65 | — | — | |
| SCHEMBL11298065 | 0.65 | — | — | |
| SCHEMBL11230982 | 0.65 | — | — | |
| SCHEMBL11399167 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10774171-B2 | Energetic compounds and compositions | TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) | 2020-09-15 | — | — | US | disclosed |
| US-20190092895-A1 | ENERGETIC COMPOUNDS AND COMPOSITIONS | TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) | 2019-03-28 | — | — | US | disclosed |
| US-10196477-B2 | Energetic compounds and compositions | TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) | 2019-02-05 | — | — | US | disclosed |
| US-20170226270-A1 | ENERGETIC COMPOUNDS AND COMPOSITIONS | TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) | 2017-08-10 | — | — | US | disclosed |
| US-20170226270-A1 | ENERGETIC COMPOUNDS AND COMPOSITIONS | TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) | 2017-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190092895-A1 | ENERGETIC COMPOUNDS AND COMPOSITIONS | GNA11, THEM6, TXN2 | ALDH1A1 3074/4885 |
| US-10196477-B2 | Energetic compounds and compositions | GNA11, THEM6, TXN2 | ALDH1A1 3083/4885 |
| US-20170226270-A1 | ENERGETIC COMPOUNDS AND COMPOSITIONS | GNA11, THEM6, TXN2 | ALDH1A1 3083/4885 |
| US-10774171-B2 | Energetic compounds and compositions | GNA11, THEM6, TXN2 | ALDH1A1 3074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.